Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1838
  • Home
  • Print this page
  • Email this page


 
   Table of Contents      
ORIGINAL ARTICLE
Year : 2019  |  Volume : 67  |  Issue : 7  |  Page : 1121-1126

Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort


1 Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L V Prasad Eye Institute, Banjara Hills, Hyderabad, Telangana, India; Retina and Uveitis Department, GMR Varalakshmi Campus, L V Prasad Eye Institute, Hanumanthawaka Junction, Visakhapatnam, Andhra Pradesh, India
2 Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L V Prasad Eye Institute, Banjara Hills, Hyderabad, Telangana, India

Date of Submission22-Oct-2018
Date of Acceptance19-Feb-2019
Date of Web Publication25-Jun-2019

Correspondence Address:
Dr. Jay Chhablani
Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, L V Prasad Eye Institute, Banjara Hills, Hyderabad - 34
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_1757_18

Rights and Permissions
  Abstract 


Purpose: To report the prevalence of pachydrusen and their relationship with subfoveal choroidal thickness (SFCT) and large choroidal vessel layer thickness (SF-LCVT) in eyes with polypoidal choroidal vasculopathy (PCV) and their fellow eyes. Methods: The case records of 50 patients (99 eyes; 59 PCV and 40 fellow eyes) were retrospectively analyzed for the presence of pachydrusen and other drusen types such as soft drusen. The diagnosis was established using colour fundus photography and optical coherence tomography (OCT). SFCT and SF-LCVT were measured and correlated with the different types of drusen. Results: The mean age of the study cohort was 62.26 ± 10.67 years and included 27 males and 23 females. Pachydrusen and soft drusen were seen in 14 (PCV: 8 and fellow eyes: 6) and 8 eyes (PCV: 2 and fellow eyes: 6) respectively. The mean SFCT and SF-LCVT in the eyes with and without pachydrusen was not significanty different (280.29 ± 103.11 μ vs. 292.63 ± 87.17 μ; P = 0.63 and 180.57 ± 59.20 vs. 173.73 ± 54.86 μ; P = 0.67, respectively). The pachydrusen were most commonly located near the vascular arcades and showed scattered distribution pattern. Though SFCT and SF-LCVT was lower in the eyes with soft drusen compared to eyes with pachydrusen, it failed to reach statistical significance (SFCT, P = 0.1 and SF-LCVT, P = 0.06). Conclusion: The prevalence of pachydrusen in PCV and their fellow eyes is lower in Indian population suggestive of ethnic variations. SFCT and SF-LCVT was not noted to vary signifcantly in eyes with and without pachydrusen in this study cohort.

Keywords: Choroidal thickness (CT), large choroidal vessel thickness (LCVT), optical coherence tomography (OCT), pachydrusen, polypoidal choroidal vasculopathy (PCV), soft drusen


How to cite this article:
Singh SR, Chakurkar R, Goud A, Rasheed MA, Vupparaboina KK, Chhablani J. Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort. Indian J Ophthalmol 2019;67:1121-6

How to cite this URL:
Singh SR, Chakurkar R, Goud A, Rasheed MA, Vupparaboina KK, Chhablani J. Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort. Indian J Ophthalmol [serial online] 2019 [cited 2019 Jul 18];67:1121-6. Available from: http://www.ijo.in/text.asp?2019/67/7/1121/261016



Drusen are the extracellular deposits located between retinal pigment epithelium (RPE) and bruch's membrane and have been commonly described in age related macular degeneration (AMD).[1],[2],[3],[4] The classical description of drusen in age related eye disease study (AREDS) was based on the size and number of drusen.[3] The classification included small, intermediate, and large drusen based on the size of drusen.[3] Other morphological descriptions have also been used such as hard and soft drusen based on whether drusen are discrete or confluent.[4] Spaide recently described a different type of drusen which are large sized (>125 μ) but have a different morphology, distribution pattern compared to the previously described large drusen in AREDS. Moreover, these drusen were associated with thickened choroid hence termed as pachydrusen.[5]

Pachychoroid spectrum is a recently described group of disease entities which are characterized by thickened choroid.[6] The presence of large choroidal vessel leads to the compression of medium choroidal vessel and choriocapillaris.[6],[7] Polypoidal choroidal vasculopathy (PCV) falls under the category of the pachychoroid spectrum disorders and was previously considered a subtype of AMD.[8],[9],[10] It is more common in Asians and African-Americans as compared to Caucasians.[9] The prevalence of PCV in the presumed AMD eyes of Chinese (24.5%), Japanese (54.7%), Korean (24.6%), and Taiwanese population (49%) showed significant ethnic variations.[11],[12],[13],[14] EVEREST study defined the diagnostic criteria of PCV which included the presence of aneurysmal dilatations called polyps with or without branching vascular network (BVN).[15]

Few studies have studied the prevalence of pachydrusen in AMD with prevalence ranging from 8.4% (unpublished data) to 11.7%.[5] It will be interesting to study the pachydrusen (which is associated with thickened choroid) in eyes with PCV, which is itself associated with thicker choroid. Lee et al. have reported the prevalence rates of 50% for pachydrusen in eyes with PCV and their fellow eyes in their study in South Korean population.[16] They also noted that the subfoveal choroidal thickness was significantly thicker in pachydrusen group as compared to other drusen types such as soft drusen or subretinal drusenoid deposits.[16] Our study focuses on the prevalence of pachydrusen in PCV and their fellow eyes and associated changes in subfoveal choroidal thickness (SFCT) and large choroidal vessel layer thickness (SF-LCVT) in Indian population.


  Methods Top


We retrospectively studied the consecutive patients with a diagnosis of PCV in at least one eye. The study included patients visiting the retina clinic of a tertiary center based in South India from April 2016 to July 2018. Institutional Review Board (IRB) approval was taken and all the study protocols conformed to the tenets of Declaration of Helsinki.

Treatment naïve eyes of PCV were included in the study. We analyzed the records of a total of 99 eyes (50 patients) with a diagnosis of PCV in at least one eye. PCV was diagnosed on the basis of criteria defined in EVEREST study. The presence of focal hyperfluorescence with polyps and BVN on indocyanine angiography (ICGA) confirmed the diagnosis of PCV.[15] Other additional criteria including serosanguinous pigment epithelial detachments (PED) on optical coherence tomography (OCT), presence of orangish nodular lesions or submacular hemorrhages on fundus photograph supported the diagnosis.

The exclusion criteria consisted of patients having refractive error more than 6D, other intraocular pathologies such as uveitis, diabetic retinopathy, or other retinal vascular disorders, advanced glaucoma, history of previous vitreoretinal surgeries and/or laser photocoagulation. Presence of media opacities like cataract or vitreous hemorrhage or significant submacular hemorrhage which prevented accurate assessment of fundus pathology and assessment of drusen at posterior pole were also excluded from the study.

All patients underwent comprehensive ophthalmological examination which included best corrected visual acuity (BCVA) in logarithm of minimum angle of resolution (logMAR), slit lamp examination, indirect ophthalmoscopy, fundus photography (Zeiss Visupac® FF4 and FF450-plus, Carl Zeiss, Dublin, CA), swept-source optical coherence tomography OCT (SS-OCT; Topcon DRI OCT Triton® plus) and indocyanine green angiography (ICGA) or fluorescein angiography (FFA) (HRA-II; Heidelberg Engineering, Dossenheim, Germany, Zeiss Visupac® FF4 and FF450-plus, Carl Zeiss, Dublin, CA).

Image analysis

The colour fundus photographs (50 degrees field of view involving the disc and macula) and OCT images were evaluated independently by two observers (RC, JC). In case of discrepancy in the observations, the final decision was reached after mutual consensus. PCV was classified in exudative and hemorrhagic subtypes based on the predominant clinical appearance as per the previous classifications.[10],[17]

Drusen were classified on the basis of morphological description and location of the drusen in OCT. Soft drusen were identified as yellowish confluent deposits with irregular, ill-defined margins commonly involving the macula and posterior pole. Rarely, these drusen were associated with pigmentary changes on their surface. OCT scans showed presence of sub -RPE deposits. Pachydrusen were identified on color fundus photograph by their yellowish white appearance, large size (>125 μ), and location of distribution. The various locations described for the pachydrusen are peripapillary, near arcades, and macular while the distribution pattern can be solitary, scattered, or clustered. The eyes with presence of both small, hard drusen/soft drusen and pachydrusen were included in the pachydrusen group. SFCT was measured subfoveally from the outer border of RPE to the inner border of choroido-scleral interface (CSI). Subfoveal large choroidal vessel layer thickness (SF-LCVT) was measured as the perpendicular distance between margin of CSI and inner border of a large choroidal vessel near to the fovea with a diameter of at least 100 μ.[18]

The data were tabulated and the mean with standard deviation were calculated using SPSS software (version 22; IBM Corp., New York, NY). The variation of SFCT and SFLCVT was also compared in the various sub-groups of PCV using independent t-test in normal distribution and Mann-Whitney test in non-parametric distribution pattern. P value ≤0.05 was considered statistically significant.


  Results Top


A total of 99 eyes of 50 patients (one eye phthisical) were studied. The study group comprised of eyes with PCV (59) and their fellow eyes (40). A total of 9 patients had bilateral PCV. The mean (± standard deviation [SD]) age of the patients was 62.26 ± 10.67 years and the study group included 23 males and 27 females. The baseline characteristics are detailed in [Table 1]. The mean (±SD) BCVA of the study eyes was 0.52 ± 0.66 logMAR. In the cohort, 80 eyes were phakic (43 clear lens and 37 senile cataract). One eye was aphakic and 18 were pseudophakic.
Table 1: Shows the baseline characteristics of the study eyes including patients of polypoidal choroidal vasculopathy (PCV) and their fellow eyes

Click here to view


The mean (±SD) SFCT and SF-LCVT were 290.83 ± 89.18 μ and 174.73 ± 55.24 μ respectively in the study population. The mean (±SD) SFCT (286.91 ± 83.26 μ) and SFLCVT (170.58 ± 58.51 μ) in PCV eyes were not significantly different from the SFCT (296.56 ± 98.03 μ; P = 0.59) and SFLCVT (180.79 ± 50.21 μ; P = 0.37) in the fellow eye as shown in [Table 2].
Table 2: Shows the comparison of baseline and choroidal parameters in different subgroups: Polypoidal choroidal vasculopathy (PCV) and non-PCV fellow eyes; eyes with pachydrusen and without pachydrusen

Click here to view


Among the 50 patients (99 eyes) studied, pachydrusen were found in 14 eyes (14.14%) while 8 eyes (8.08%) had presence of soft drusen. The prevalence of pachydrusen in PCV and fellow eyes was comparable with presence of pachydrusen in 8 PCV eyes (13.56%) and 6 non-PCV fellow eyes (15%). Out of the 8 PCV eyes with pachydrusen, 4 eyes had hemorrhagic PCV and 4 had exudative PCV.

The mean SFCT was 280.29 ± 103.11 μ in the eyes with pachydrusen as compared to 292.63 ± 87.17 μ in those without pachydrusen—a difference that was not found significant (p = 0.63). The mean SFLCVT was 180.57 ± 59.20 μ in the eyes with pachydrusen as compared to 173.73 ± 54.86 μ in those without pachydrusen—a difference that was again not found significant (p = 0.67). Eyes with pachydrusen were also not found to have a difference with soft drusen in terms of mean SFCT (280.29 ± 103.11 μ Vs 200.13 ± 114.18 μ; P = 0.1) and mean SFLCVT (180.57 ± 59.20 μ vs. 130.5 ± 53.37 μ; P = 0.06).

The distribution patterns of pachydrusen were also detailed with respect to the location and arrangement of drusen. The most common location was near the vascular arcades (9 eyes), peripapillary (3 eyes) and macular (2 eyes) whereas the arrangement pattern for pachydrusen was scattered (6) followed by clustered (4) and solitary drusen (4). Representative cases are shown as [Figure 1] and [Figure 2]. Three eyes had presence of both soft drusen and pachydrusen and were included in the group with pachydrusen.
Figure 1: Fundus photograph (a) shows subretinal heme nasal to fovea and subretinal exudation whereas (d) shows subfoveal small, hard drsuen and pachydrusen superior to fovea (yellow circle). Late phase indocyanine angiography (b, e) shows focal hyperfluorescence suggestive of polyp in right eye and hypofluorescence corresponding to pachydrusen in left eye. OCT (c) shows PED, subretinal fluid and intraretinal hyper-reflectivity. Vertical OCT scan (f) shows homogenous deposit at sub RPE level with pachydrusen (arrow). SFCT was 318 and 286 microns in right and left eye respectively

Click here to view
Figure 2: Fundus photograph (a) of an eye with PCV showing pachydrusen (yellow circle) with hard exudates superior to fovea. Early and late phase ICGA (b, c) show branching vascular network, focal hyperfluorescence due to polyp and hypofluorescence corresponding to pachydrusen (arrow). OCT showed intraretinal, subretinal fluid, subretinal hyperreflectivity and PED with SFCT of 206 microns (d). The corresponding vertical OCT scan (e) shows homogenous deposit below retinal pigment epithelium (RPE) suggestive of pachydrusen (yellow arrow)

Click here to view


FFA and ICG were done for 43 (out of 50) —a total of 86 among 99 eyes. Cases in which the diagnosis was straightforward based on clinical and OCT signs, ICGA was not performed. Pachydrusen showed mild hyperfluorescence in both FA and ICGA in majority of the patients (8/14 eyes). However, 6 eyes with pachydrusen showed early and late hypofluorescence in both FA and ICGA [Figure 1] and [Figure 2].


  Discussion Top


The prevalence of pachydrusen in PCV and their fellow eyes in our study involving Indian cohort was 14.14% which is significantly lesser compared to similar study by Lee et al. in Korean population where they have reported a prevalence rate of 50%.[16] This difference could be due to the ethnic variations and difference in morphological expression of the disease in different population. This is supported by the fact that variable incidence rates of PCV in Asian (24%–54%) and Caucasian (4%–13%) eyes have been shown in various publications.[11],[13],[19],[20],[21]

Eight eyes had presence of soft drusen (2 PCV eyes and 6 non-PCV fellow eyes). The SFCT and SF-LCVT though not statistically different, it showed a tendency towards reduced CT in eyes with soft drusen as compared to eyes with pachydrusen. Spaide first described pachydrusen in eyes with non-neovascular AMD with a prevalence rate of 11.7% in Caucasian population.[5] We have reported the prevalence of pachydrusen (8.4%; 12/143 eyes) in AMD was in Indian population (unpublished data). Spaide hypothesized that the presence of different types of drusen may have a direct correlation with CT. SDD, soft drusen and pachydrusen were present in thin choroid, choroid with normal thickness, and thickened choroid, respectively.[5]

Previous authors have characterized the pachydrusen and differentiated them from soft drusen based on the complex and irregular shape with a well-defined outer border.[5],[16] The description of pachydrusen is based on the choroidal thickness, size of drusen, and its distribution. The common locations described are peripapillary, near vascular arcades, and macular with distribution pattern such as solitary, scattered, and clustered.[16] In our series, the most common pattern seen was scattered pachydrusen near the vascular arcades.

The similar prevalence of pachydrusen in PCV and non-PCV eyes suggests bilaterally symmetrical distribution pattern and that pachydrusen may not be directly involved in the disease activity and clinical manifestation of the disease. This observation was also seen in the study by Lee et al.[16] Similarly, pachydrusen were seen in both hemorrhagic (4 eyes) and exudative PCV (4 eyes) with no preponderance for any subtype. Though pachydrusen in most of the eyes showed an early and late mild hyperfluorescence, 6 eyes showed a hypofluorescence in both FFA and ICGA. The variation in staining pattern of different types of drusen has been shown in multiple studies and appears to correlate with their chemical composition.[22],[23]

Recently, PCV has been classified in the pachychoroid spectrum related disorders and has been associated with increased choroidal thickness.[6],[7] The fellow eyes of PCV were noted to have a slightly higher SFCT and SF-LCVT which was not statistically significant as compared to eyes with PCV. This suggests that the CT changes happen bilaterally in eyes with PCV and the asymptomatic fellow eyes. Lee et al. have reported slightly higher SFCT in fellow eyes of PCV as compared to the PCV eyes.[16] We also noted similar findings in eyes with and without pachydrusen with no significant difference between the two groups. The above two observations show the nonadditive effect of PCV and pachydrusen related to CT.

The results of previous study in nonexudative AMD eyes may not be applicable to eyes with PCV as eyes with AMD and PCV show different pathophysiology along with difference in CT. PCV is associated with increase in choroidal vascular hyperpermeability and presence of pachyvessels.[6],[7],[24],[25],[26] On the other hand, AMD is characterized by choroidal thinning.[26],[27] Moreover, previous reports have also shown reduced number of drusen in eyes with PCV as compared to the AMD.[11],[28],[29]

The results need to be analyzed considering the limitations of this study. The study was retrospective, cross-sectional and included a small number of patients. The data were obtained from the visiting patients in a referral hospital. This does not provide the true estimates of the prevalence of pachydrusen in the population. The study lacks longitudinal follow up of the patients which could have provided more information on the natural progression of drusen and their effects on CT and LCVT.


  Conclusion Top


The current study provides an outlook regarding the newly described type pachydrusen in eyes with PCV and their fellow eyes. Whether these represent a morphological variation of drusen in these eyes or carry prognostication potential in terms of visual acuity and course of the disease is unclear at present. Future, longitudinal studies focused on these aims may provide more insight into the pathogenesis and natural course of these drusen.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Green WR. Histopathology of age-related macular degeneration. Mol Vis 1999;5:27.  Back to cited text no. 1
    
2.
Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The wisconsin age-related maculopathy grading system. Ophthalmology 1991;98:1128-34.  Back to cited text no. 2
    
3.
Age-Related Eye Disease Study Research Group. The age-related eye disease study (AREDS): Design implications AREDS report No. 1. Control Clin Trials. 1999;20:573-600.  Back to cited text no. 3
    
4.
Sarks JP, Sarks SH, Killingsworth MC. Evolution of soft drusen in age-related macular degeneration. Eye (Lond) 1994;8:269-83.  Back to cited text no. 4
    
5.
Spaide RF. Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina 2018;38:708-16.  Back to cited text no. 5
    
6.
Gallego-Pinazo R, Dolz-Marco R, Gómez-Ulla F, Mrejen S, Freund KB. Pachychoroid diseases of the macula. Med Hypothesis Discov Innov Ophthalmol 2014;3:111-5.  Back to cited text no. 6
    
7.
Dansingani KK, Balaratnasingam C, Naysan J, Freund KB. En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina 2016;36:499-516.  Back to cited text no. 7
    
8.
Laude A, Cackett PD, Vithana EN, Yeo IY, Wong D, Koh AH, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease? Prog Retin Eye Res 2010;29:19-29.  Back to cited text no. 8
    
9.
Wong CW, Yanagi Y, Lee WK, Ogura Y, Yeo I, Wong TY, et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 2016;53:107-39.  Back to cited text no. 9
    
10.
Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, et al. Polypoidal choroidal vasculopathy: Definition, pathogenesis, diagnosis, and management. Ophthalmology 2018;125:708-24.  Back to cited text no. 10
    
11.
Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007;144:15-22.  Back to cited text no. 11
    
12.
Liu Y, Wen F, Huang S, Luo G, Yan H, Sun Z, et al. Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol 2007;245:1441-5.  Back to cited text no. 12
    
13.
Byeon SH, Lee SC, Oh HS, Kim SS, Koh HJ, Kwon OW. Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol 2008;52:57-62.  Back to cited text no. 13
    
14.
Chang YC, Wu WC. Polypoidal choroidal vasculopathy in Taiwanese patients. Ophthalmic Surg Lasers Imaging 2009;40:576-81.  Back to cited text no. 14
    
15.
Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, et al. EVEREST study: Efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 2012;32:1453-64.  Back to cited text no. 15
    
16.
Lee J, Byeon SH. Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: Multimodal Image Study. Retina 2018 doi: 10.1097/IAE.0000000000002019. [Epub ahead of print].  Back to cited text no. 16
    
17.
Koh AH, Chen LJ, Chen SJ, Chen Y, Giridhar A, Iida T, et al. Polypoidal choroidal vasculopathy: Evidence-based guidelines for clinical diagnosis and treatment. Retina 2013;33:686-716.  Back to cited text no. 17
    
18.
Branchini LA, Adhi M, Regatieri CV, Nandakumar N, Liu JJ, Laver N, et al. Analysis of choroidal morphology and vasculature in healthy eyes using spectral-domain optical coherence tomography. Ophthalmology 2013;120:1901-8.  Back to cited text no. 18
    
19.
Lafaut BA, Leys AM, Snyers B, Rasquin F, De Laey JJ. Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol 2000;238:752-9.  Back to cited text no. 19
    
20.
Yannuzzi LA, Wong DW, Sforzolini BS, Goldbaum M, Tang KC, Spaide RF, et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999;117:1503-10.  Back to cited text no. 20
    
21.
Scassellati-Sforzolini B, Mariotti C, Bryan R, Yannuzzi LA, Giuliani M, Giovannini A. Polypoidal choroidal vasculopathy in Italy. Retina 2001;21:121-5.  Back to cited text no. 21
    
22.
Friedman D, Parker JS, Kimble JA, Delori FC, McGwin G, Jr., Curcio CA. Quantification of fluorescein-stained drusen associated with age-related macular degeneration. Retina 2012;32:19-24.  Back to cited text no. 22
    
23.
Spaide RF, Curcio CA. Drusen characterization with multimodal imaging. Retina 2010;30:1441-54.  Back to cited text no. 23
    
24.
Baek J, Lee JH, Jung BJ, Kook L, Lee WK. Morphologic features of large choroidal vessel layer: Age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2018;256:2309-17.  Back to cited text no. 24
    
25.
Sasahara M, Tsujikawa A, Musashi K, Gotoh N, Otani A, Mandai M, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 2006;142:601-7.  Back to cited text no. 25
    
26.
Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, et al. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2012;53:3663-72.  Back to cited text no. 26
    
27.
Manjunath V, Goren J, Fujimoto JG, Duker JS. Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography. Am J Ophthalmol 2011;152:663-8.  Back to cited text no. 27
    
28.
Yoshimura N. [Age-related macular degeneration in the Japanese]. Nippon Ganka Gakkai Zasshi 2016;120:163-88; discussion 189.  Back to cited text no. 28
    
29.
Mori K, Horie-Inoue K, Gehlbach PL, Takita H, Kabasawa S, Kawasaki I, et al. Phenotype and genotype characteristics of age-related macular degeneration in a Japanese population. Ophthalmology 2010;117:928-38.  Back to cited text no. 29
    


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
Methods
Results
Discussion
Conclusion
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed119    
    Printed0    
    Emailed0    
    PDF Downloaded46    
    Comments [Add]    

Recommend this journal